MAZE THERAPEUTICS INC
MAZE·578784100·US·Common Stock·Healthcare - Biotechnology-13D/G
MAZE (MAZE THERAPEUTICS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($85.3M), BlackRock, Inc. ($76.7M), VANGUARD CAPITAL MANAGEMENT LLC ($42.9M). Net institutional sentiment: Bullish.
92
Holders
(5 Elite)
$580.3M
Total Value
70% (94)
Consensus
66 buying - 28 selling
13F: Insider & Congress:
Who's Trading
InsiderBHBernstein HaroldSell $400KJul 1, 2026
InsiderBHBernstein HaroldSell $36KJul 1, 2026
InsiderDADandekar AtulSell $210KJun 29, 2026
InsiderCVColoma Jason VSell $622KJun 23, 2026
InsiderCVColoma Jason VSell $51KJun 22, 2026
InsiderCVColoma Jason VSell $53KJun 22, 2026
InsiderBHBernstein HaroldSell $339KJun 1, 2026
InsiderBHBernstein HaroldSell $42KJun 1, 2026
ActivistPBParadigm BioCapital Advisors LP6.1%Apr 1, 2026
Showing 1-20 of 99
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer